SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+2.97%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.24B
AUM Growth
+$1.24B
(-6.3%)
Cap. Flow
-$27.3M
Cap. Flow
% of AUM
-2.21%
Top 10 Holdings %
Top 10 Hldgs %
21.29%
Holding
139
New
26
Increased
28
Reduced
58
Closed
12
Top Buys
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$24.3M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$23.4M |
| 3 |
Aveanna Healthcare
AVAH
|
$20.5M |
| 4 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
$19.9M |
| 5 |
AGTI
Agiliti, Inc.
AGTI
|
$18.1M |
Top Sells
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
$32.3M |
| 2 |
Novavax
NVAX
|
$21.8M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$17.2M |
| 4 |
Arvinas
ARVN
|
$14.4M |
| 5 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$13.1M |
Sector Composition
| 1 | Healthcare | 94.02% |
| 2 | Industrials | 4.68% |
| 3 | Financials | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Regeneron Pharmaceuticals
REGN
$59.8B
| $2.36M | 0.19% |
4,220
-400
| -9% | -$223K |
|
|
LATN
102
DELISTED
Union Acquisition Corp. II Ordinary Shares
LATN
| $2.18M | 0.18% |
+215,582
| New | +$2.18M |
|
|
ONC
103
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $2.06M | 0.17% |
6,000
+200
| +3% | +$68.6K |
|
104
CryoPort
CYRX
$426M
| $2.03M | 0.16% |
32,234
-34,800
| -52% | -$2.2M |
|
105
Gilead Sciences
GILD
$140B
| $2.01M | 0.16% |
29,250
| – | – |
|
106
Vertex Pharmaceuticals
VRTX
$102B
| $1.96M | 0.16% |
9,721
-1,600
| -14% | -$323K |
|
107
Illumina
ILMN
$15.2B
| $1.87M | 0.15% |
3,960
-200
| -5% | -$94.4K |
|
108
Cytosorbents Corp
CTSO
$61.5M
| $1.85M | 0.15% |
244,660
-28,000
| -10% | -$211K |
|
109
Zai Lab
ZLAB
$3.48B
| $1.04M | 0.08% |
5,900
| – | – |
|
110
IQVIA
IQV
$31.4B
| $727K | 0.06% |
+3,000
| New | +$727K |
|
111
Incyte
INCY
$17B
| $691K | 0.06% |
8,210
| – | – |
|
|
KLRS
112
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $690K | 0.06% |
34,950
+13,500
| +63% | +$266K |
|
113
argenx
ARGX
$44.2B
| $563K | 0.05% |
1,870
| – | – |
|
114
CRISPR Therapeutics
CRSP
$4.82B
| $529K | 0.04% |
3,270
| – | – |
|
115
Dr. Reddy's Laboratories
RDY
$11.8B
| $474K | 0.04% |
6,454
| – | – |
|
116
Ascendis Pharma
ASND
$12.1B
| $467K | 0.04% |
3,550
+300
| +9% | +$39.5K |
|
117
Generation Bio
GBIO
$40.3M
| $444K | 0.04% |
16,522
-5,000
| -23% | -$134K |
|
|
MRTX
118
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $393K | 0.03% |
2,431
-76,650
| -97% | -$12.4M |
|
|
AFMD
119
DELISTED
Affimed
AFMD
| $383K | 0.03% |
+45,000
| New | +$383K |
|
120
MEI Pharma
MEIP
$149M
| $368K | 0.03% |
128,980
-1,832,687
| -93% | -$5.23M |
|
121
Aligos Therapeutics
ALGS
$75.1M
| $345K | 0.03% |
16,908
-1,800
| -10% | -$36.7K |
|
122
Instil Bio
TIL
$196M
| $326K | 0.03% |
16,878
-360,372
| -96% | -$6.96M |
|
123
Legend Biotech
LEGN
$6.64B
| $304K | 0.02% |
7,400
-2,900
| -28% | -$119K |
|
|
RAIN
124
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $282K | 0.02% |
+18,155
| New | +$282K |
|
125
Cogent Biosciences
COGT
$1.83B
| $219K | 0.02% |
27,000
| – | – |
|